Tight Junctions and the Intestinal Barrier

Physiology of the Gastrointestinal Tract

Volumn 2, Issue , 2006, Pages 1559-1594

  Ma, Thomas Y ^a   Anderson, James M ^b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884010081     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088394-3/50064-7     Document Type: Chapter

References (348)

1. Madara JL, Anderson JM Epithelia: biologic principles of organization. Textbook of gastroenterology 2003, 151-165. Lippincott Williams & Wilkins, Philadelphia. 4th ed. T. Yamada, D.H. Alpers, N. Kaplowitz, L. Laine, C. Owynag, D.W. Powell (Eds.).
2. Finkelstein A Nature of the water permeability increase induced by antidiuretic hormone (ADH) in toad urinary bladder and related tissues. J Gen Physiol 1976, 68:137-143.
3. Bonnet R Dtsch Med Wochenschr 1895, 21:58.
4. Farquhar MG and Palade GE. Junctional complexes in various epithelia. J Cell Biol.
5. Madara JL, Carlson S Supraphysiologic L-tryptophan elicits cytoskeletal and macromolecular permeability alterations in hamster small intestinal epithelium in vitro. J Clin Invest 1991, 87:454-462.
6. Fanning AS, Jameson BJ, Jesaitis LA, Anderson JM The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem 1998, 273:29745-29753.
7. D'Atri F, Citi S Cingulin interacts with F-actin in vitro. FEBS Lett 2001, 507:21-24.
8. Cacev T, Jokic M, Spaventi R, Pavelic K, Kapitanovic S Loss of heterozygosity testing using real-time PCR analysis of single nucleotide polymorphisms. J Cancer Res Clin Oncol 2006, 132(3):200-204. Epub 2005 Nov 8.
9. Nathke IS The adenomatous polyposis coli protein: the Achilles heel of the gut epithelium. Annu Rev Cell Dev Biol 2004, 20:337-366.
10. Leite MF, Hirata K, Pusl T, Burgstahler AD, Okazaki K, Ortega JM, Goes AM, Prado MA, Spray DC, Nathanson MH Molecular basis for pacemaker cells in epithelia. J Biol Chem 2002, 277:16313-16323.
11. Furuse M, Sasaki H, Fujimoto K, Tsukita S A single gene product claudin-1 or-2 reconstitutes tight junction strands and recruits occludin in fibroblasts. J Cell Biol 1998, 143:391-401.
12. Claude P Morphological factors influencing transepithelial permeability: a model for the resistance of the zonula occludens. J Membr Biol 1978, 39(2-3):219-232.
13. Madara JL, Trier JS, Neutra MR Structural changes in the plasma membrane accompanying differentiation of epithelial cells in human and monkey small intestine. Gastroenterology 1980, 78(5):963-975. pt l.
14. Powell DW Barrier function of epithelia. Am J Physiol 1981, 241:G275-G288.
15. Diamond JM Channels in epithelial cell membranes and junctions. Fed Proc 1978, 37:2639-2643.
16. Reuss L Tight junction permeability to ions and water. Tight junctions 2001, 61-88. CRC Press, Boca Raton, FL. 2nd ed. M. Cereijido, J.M. Anderson (Eds.).
17. Fromter E, Diamond J Route of passive ion permeation in epithelia. Nat New Biol 1972, 235:9-13.
18. Gitter AH, Bendfeldt K, Schulzke JD, Fromm M Leaks in the epithelial barrier caused by spontaneous and TNF-alpha-induced single-cell apoptosis. FASEB J 2000, 14:1749-1753.
19. Van Itallie CM, Anderson JM The role of claudins in determining paracellular charge selectivity. Proc Am Thorac Soc 2004, 1:38-41.
20. Russo MA, Hogenauer C, Coates SW, Santa Ana CA, Porter JL, Rosenblatt RL, Emmett M, Fordtran JS Abnormal passive chloride absorption in cystic fibrosis jejunum functionally opposes the classic chloride secretory defect. J Clin Invest 2003, 112:118-125.
21. Hoffmann B, Nagel I, Clauss W Aldosterone regulates paracellular pathway resistance in rabbit distal colon. J Comp Physiol [B] 1990, 160:381-388.
22. Yu AS Claudins and epithelial paracellular transport: the end of the beginning. Curr Opin Nephrol Hypertens 2003, 12:503-509.
23. Tang VW, Goodenough DA Paracellular ion channel at the tight junction. Biophys J 2003, 84:1660-1673.
24. Firth JA Endothelial barriers: from hypothetical pores to membrane proteins. J Anat 2002, 200:541-548.
25. Salas PJ, Moreno JH Single-file diffusion multi-ion mechanism of permeation in paracellular epithelial channels. J Membr Biol 1982, 64(1-2):103-112.
26. Watson CJ, Rowland M, Warhurst G Functional modeling of tight junctions in intestinal cell monolayers using polyethylene glycol oligomers. Am J Physiol Cell Physiol 2001, 281:C388-C397.
27. Ma TY, Hoa NT, Tran DD, Bui V, Pedram A, Mills S, Merryfield M Cytochalasin B modulation of Caco-2 tight junction barrier: role of myosin light chain kinase. Am J Physiol Gastrointest Liver Physiol 2000, 279:G875-G885.
28. Madara JL, Stafford J, Barenberg D, Carlson S Functional coupling of tight junctions and microfilaments in T84 monolayers. Am J Physiol 1988, 254(3):G416-G423. pt 1.
29. Madara JL, Moore R, Carlson S Alteration of intestinal tight junction structure and permeability by cytoskeletal contraction. Am J Physiol 1987, 253(6):C854-C861. pt 1.
30. Ma TY, Hollander D, Erickson RA, Truong H, Krugliak P Is the small intestinal epithelium truly "tight" to inulin permeation?. Am J Physiol 1991, 260(5):G669-G676. pt 1.
31. Pappenheimer JR, Reiss KZ Contribution of solvent drag through intercellular junctions to absorption of nutrients by the small intestine of the rat. J Membr Biol 1987, 100:123-136.
32. Stevenson BR, Siliciano JD, Mooseker MS, Goodenough DA Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J Cell Biol 1986, 103:755-766.
33. Martin-Padura I, Lostaglio S, Schneemann M, Williams L, Romano M, Fruscella P, Panzeri C, Stoppacciaro A, Ruco L, Villa A, Simmons D, Dejana E Junctional adhesion molecule a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigratio. J Cell Biol 1998, 142:117-127.
34. Philipson L, Pettersson RF The coxsackie-adenovirus receptor-a new receptor in the immunoglobulin family involved in cell adhesion. Curr Top Microbiol Immunol 2004, 273:87-111.
35. Arrate MP, Rodriguez JM, Tran TM, Brock TA, Cunningham SA Cloning of human junctional adhesion molecule 3 (JAM3) and its identification as the JAM2 counter-receptor. J Biol Chem 2001, 276:45826-45832.
36. Cunningham SA, Arrate MP, Rodriguez JM, Bjercke RJ, Vanderslice P, Morris AP, Brock TA A novel protein with homology to the junctional adhesion molecule. Characterization of leukocyte interactions. J Biol Chem 2000, 275:34750-34756.
37. Kucharzik T, Walsh SV, Chen J, Parkos CA, Nusrat A Neutrophil trans-migration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am J Pathol 2001, 159:2001-2009.
38. Van Itallie CM, Anderson JM Occludin confers adhesiveness when expressed in fibroblasts. J Cell Sci 1997, 110:1113-1121. pt 9.
39. Sakakibara A, Furuse M, Saitou M, Ando-Akatsuka Y, Tsukita S Possible involvement of phosphorylation of occludin in tight junction formation. J Cell Biol 1997, 137:1393-1401.
40. Sakakibara A, Furuse M, Saitou M, Ando-Akatsuka Y, Tsukita S Possible involvement of phosphorylation of occludin in tight junction formation. J Cell Biol 1997, 137(6):1393-1401.
41. McCarthy KM, Skare IB, Stankewich MC, Furuse M, Tsukita S, Rogers RA, Lynch RD, Schneeberger EE Occludin is a functional component of the tight junction. J Cell Sci 1996, 109:2287-2298. pt 9.
42. Saitou M, Furuse M, Sasaki H, Schulzke JD, Fromm M, Takano H, Noda T, Tsukita S Complex phenotype of mice lacking occludina component of tight junction strands. Mol Biol Cell 2000, 11:4131-4142.
43. Barrios-Rodiles M, Brown KR, Ozdamar B, Bose R, Liu Z, Donovan RS, Shinjo F, Liu Y, Dembowy J, Taylor IW, Luga V, Przulj N, Robinson M, Suzuki H, Hayashizaki Y, Jurisica I, Wrana JL High-throughput mapping of a dynamic signaling network in mammalian cells. Science 2005, 307:1621-1625.
44. Chen YH, Lu Q, Goodenough DA, Jeansonne B Nonreceptor tyrosine kinase c-Yes interacts with occludin during tight junction formation in canine kidney epithelial cells. Mol Biol Cell 2002, 13:1227-1237.
45. Brone B, Eggermont J PDZ proteins retain and regulate membrane transporters in polarized epithelial cell membranes. Am J Physiol Cell Physiol 2005, 288:C20-C29.
46. Matter K, Balda MS Signalling to and from tight junctions. Nat Rev Mol Cell Biol 2003, 4:225-236.
47. Nusrat A, Turner JR, Madara JL Molecular physiology pathophys-iology of tight junctions. IV Regulation of tight junctions by extracel-lular stimuli: nutrients cytokines and immune cells. Am J Physiol Gastrointest Liver Physiol 2000, 279:G851-G857.
48. Karczewski J, Groot J Molecular physiology pathophysiology^of tight junctions. III Tight junction regulation by intracellular messengers: differences in response within and between. Am J Physiol Gastrointest Liver Physiol 2000, 279:G660-G665.
49. Kale G, Naren AP, Sheth P, Rao RK Tyrosine phosphorylation of occludin attenuates its interactions with ZO-1 ZO-2and ZO-3. Biochem Biophys Res Commun 2003, 302:324-329.
50. Yamamoto Y, Nishimura N, Morimoto S, Kitamura H, Manabe S, Kanayama H, Kagawa S, Sasaki T Distinct roles of Rab3B Rabl3 in the polarized transport of apical basolateral and tight junctional membrane proteins to the plasma membrane. Biochem Biophys Res Commun 2003, 308:270-275.
51. Hamazaki Y, Itoh M, Sasaki H, Furuse M, Tsukita S Multi-PDZ domain protein 1 (MUPP1) is concentrated at tight junctions through its possible interaction with claudin-1 and junctional adhesion molecule. J Biol Chem 2002, 277:455-461.
52. Zhadanov AB, Provance DW, Speer CA, Coffin JD, Goss D, Blixt JA, Reichert CM, Mercer JA Absence of the tight junctional protein AF-6 disrupts epithelial cell-cell junctions and cell polarity during mouse development. Curr Biol 1999, 9:880-888.
53. Benais-Pont G, Punn A, Flores-Maldonado C, Eckert J, Raposo G, Fleming TP, Cereijido M, Balda MS, Matter K Identification of a tight junction-associated guanine nucleotide exchange factor that activates Rho and regulates paracellular permeability. J Cell Biol 2003, 160:729-740.
54. Mitic LL, Van Itallie CM, Anderson JM Molecular physiology pathophysiology of tight junctions. I. Tight junction structure and function: lessons from mutant animals and proteins. Am J Physiol Gastrointest Liver Physiol 2000, 279:G250-G254.
55. D'Atri F, Citi S Molecular complexity of vertebrate tight junctions. Mol Membr Biol 2002, 19:103-112.
56. Balda MS, Garrett MD, Matter K The ZO-1-associated Y-box factor ZONAB regulates epithelial cell proliferation and cell density. J Cell Biol 2003, 160:423-432.
57. Joberty G, Petersen C, Gao L, Macara IG The cell-polarity protein Par6 links Par3 and atypical protein kinase C to Cdc42. Nat Cell Biol 2000, 2:531-539.
58. Roh MH, Liu CJ, Laurinec S, Margolis B The carboxyl terminus of zona occludens-3 binds and recruits a mammalian homologue of discs lost to tight junctions. J Biol Chem 2002, 277:27501-27509.
59. Nunbhakdi-Craig V, Machleidt T, Ogris E, Bellotto D, White CL, Sontag E Protein phosphatase 2A associates with and regulates atypical PKC and the epithelial tight junction complex. J Cell Biol 2002, 158:967-978.
60. Macara IG Parsing the polarity code. Nat Rev Mol Cell Biol 1904, 5:220-231.
61. Schneeberger EE, Lynch RD The tight junction: a multifunctional complex. Am J Physiol Cell Physiol 2004, 286:C1213-C1228.
62. Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S Claudin-1 and-2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 1998, 141:1539-1550.
63. Furuse M, Sasaki H, Tsukita S Manner of interaction of heterogeneous claudin species within and between tight junction strands. J Cell Biol 1999, 147:891-903.
64. Itoh M, Furuse M, Morita K, Kubota K, Saitou M, Tsukita S Direct binding of three tight junction-associated MAGUKs ZO-1 ZO-2 ZO-3 with the COOH termini of claudins. J Cell Biol 1999, 147:1351-1363.
65. Jeansonne B, Lu Q, Goodenough DA, Chen YH Claudin-8 interacts with multi-PDZ domain protein 1 (MUPP1) and reduces paracellular conductance in epithelial cells. Cell Mol Biol (Noisy-le-grand) 2003, 49:13-21.
66. Simon DB, Lu Y, Choate KA, Velazquez H, Al Sabban E, Praga M, Casari C, Bettinelli A, Colussi C, Rodriguez-Soriano J, McCredie D, Milford D, Sanjad S, Lifton RP Paracellin-1 a renal tight junction protein required for paracellular Mg2+ resorption. Science 1999, 285:103-106.
67. Gow A, Southwood CM, Li JS, Pariali M, Riordan GP, Brodie SE, Danias J, Bonstein JM, Kachar B, Lazzarini RA CNS myelin and sertoli cell tight junction strands are absent in Osp/claudin-11 null mice. Cell 1999, 99(6):649-659.
68. Fukuhara A, Shimizu K, Kawakatsu T, Fukuhara T Takai Y Involvement of nectin-activated Cdc42 small G protein in organization of adherens and tight junctions in Madin-Darby canine kidney cells. J Biol Chem 2003, 278:51885-51893.
69. Turksen K, Troy TC Claudin-6: a novel tight junction molecule is developmentally regulated in mouse embryonic epithelium. Dev Dyn 2001, 222:292-300.
70. Rahner C, Mitic LL, Anderson JM Heterogeneity in expression subcellular localization of claudins 234 and 5 in the rat liver pancreas and gut. Gastroenterology 2001, 120:411-422.
71. Tepass U Claudin complexities at the apical junctional complex. Nat Cell Biol 2003, 5:595-597.
72. Loh YH, Christoffels A, Brenner S, Hunziker W, Venkatesh B Extensive expansion of the claudin gene family in the teleost fish Fugu rubripes. Genome Res 2004, 14:1248-1257.
73. Behr M, Riedel D, Schuh R The claudin-like megatrachea is essential in septate junctions for the epithelial barrier function in Drosophila. Dev Cell 2003, 5:611-620.
74. Tepass U, Tanentzapf G, Ward R, Fehon R Epithelial cell polarity and cell junctions in Drosophila. Annu Rev Genet 2001, 35:747-784.
75. Wu VM, Schulte J, Hirschi A, Tepass U, Beitel GJ Sinuous is a Drosophila claudin required for septate junction organization and epithelial tube size control. J Cell Biol 2004, 164:313-323.
76. Asano A, Asano K, Sasaki H, Furuse M, Tsukita S Claudins in Caenorhabditis elegans: their distribution and barrier function in the epithelium. Curr Biol 2003, 13:1042-1046.
77. McCarthy KM, Francis SA, McCormack JM, Lai J, Rogers RA, Skare IB, Lynch RD, Schneeberger EE Inducible expression of claudin-1-myc but not occludin-VSV-G results in aberrant tight junction strand formation in MDCK cells. J Cell Sci 2000, 113:3387-3398. pt 19.
78. Inai T, Kobayashi J Shibata Y Claudin-1 contributes to the epithelial barrier function in MDCK cells. Eur J Cell Biol 1999, 78:849-855.
79. Furuse M, Furuse K, Sasaki H, Tsukita S Conversion of zonulae occlu-dentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J Cell Biol 2001, 153:263-272.
80. Van Itallie C, Rahner C, Anderson JM Regulated expression of claudin-4 decreases paracellular conductance through a selective decrease in sodium permeability. J Clin Invest 2001, 107:1319-1327.
81. Yu AS, Enck AH, Lencer WI, Schneeberger EE Claudin-8 expression in Madin-Darby canine kidney cells augments the paracellular barrier to cation permeation. J Biol Chem 2003, 278:17350-17359.
82. J Biol Chem 2004, 279:51714.
83. Agostoni E, Gobessi S, Brancolini C, Schneider C Identification and characterization of a new member of the gas3/PMP22 gene family in C elegans. Gene 1999, 234:267-274.
84. Van Itallie CM, Fanning AS, Anderson JM Reversal of charge selectivity in cation or anion-selective epithelial lines by expression of different claudins. Am J Physiol Renal Physiol 2003, 285:F1078-F1084.
85. Colegio OR, Van Itallie CM, Mccrea HJ, Rahner C, Anderson JM Claudin extracellular domains determine paracellular charge selectivity and resistance but not tight junction fibril architecture. Am J Physiol Cell Physiol 2003, 284:C1346-C1354.
86. Colegio OR, Van Itallie C, Rahner C, Anderson JM Claudin extracel-lular domains determine paracellular charge selectivity and resistance but not tight junction fibril architecture. Am J Physiol Cell Physiol 2003, 284:C1346-C1354.
87. Hadj-Rabia S, Baala L, Vabres P, Hamel-Teillac D, Jacquemin E, Fabre M, Lyonnet S, De Prost Y, Munnich A, Hadchouel M, Smahi A Claudin-1 gene mutations in neonatal sclerosing cholangitis associated with ichthyosis: a tight junction disease. Gastroenterology 2004, 127:1386-1390.
88. Hadj-Rabia S, Baala L, Vabres P, Hamel-Teillac D, Jacquemin E, Fabre M, Lyonnet S, De Prost Y, Munnich A, Hadchouel M, Smahi A Claudin-1 gene mutations in neonatal sclerosing cholangitis associated with ichthyosis: a tight junction disease. Gastroenterology 2005, 128:524. Erratum in:.
89. Wilcox ER, Burton QL, Naz S, Riazuddin S, Smith TO, Ploplis B, Belyantseva I, Ben Yosef T, Liburd NA, Morell RJ, Kachar B, Wu DK, Griffith AJ, Riazuddin S, Friedman TB Mutations in the gene encoding tight junction claudin-14 cause autosomal recessive deafness DFNB29. Cell 2001, 104:165-172.
90. Muller D, Kausalya PJ, Claverie-Martin F, Meij IC, Eggert P, Garcia-Nieto V, Hunziker W A novel claudin 16 mutation associated with childhood hypercalciuria abolishes binding to ZO-1 and results in lysosomal mistargeting. Am J Hum Genet 2003, 73:1293-1301.
91. Carlton VE, Harris BZ, Puffenberger EG, Batta AK, Knisely AS, Robinson DL, Strauss KA, Shneider BL, Lim WA, Salen G, Morton DH, Bull LN Complex inheritance of familial hypercholanemia with associated mutations in TJP2 and BAAT. Nat Genet 2003, 34:91-96.
92. Furuse M, Hata M, Furuse K, Yoshida Y, Haratake A, Sugitani Y, Noda T, Kubo A, Tsukita S Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Biol 2002, 156:1099-1 111.
93. Coucke PJ, Van Hauwe P, Kelley PM, Kunst H, Schatteman I, Van Velzen D, Meyers J, Ensink RJ, Verstreken M, Declau F, Marres H, Kastury K, Bhasin S, McGuirt WT, Smith RJH, Cremers CWRJ, Van de Heyning P, Willems PJ, Smith SD, Van Camp G Mutations in the KCNQ4 gene are responsible for autosomal dominant deafness in four DFNA2 families. Hum Mol Genet 1999, 8:1321-1328.
94. Ben Yosef T, Belyantseva IA, Saunders TL, Hughes ED, Kawamoto K, Van Itallie CM, Beyer LA, Halsey K, Gardner DJ, Wilcox ER, Rasmussen J, Anderson JM, Dolan DF, Forge A, Raphael Y, Camper SA, Friedman TB Claudin 14 knockout mice a model for autosomal recessive deafness DFNB29 are deaf due to cochlear hair cell degeneration. Hum Mol Genet 2003, 12:2049-2061.
95. Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, Furuse M, Tsukita S Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J cell Biol 2003, 161:653-660.
96. Brancolini C, Edomi P, Marzinotto S, Schneider C Exposure at the cell surface is required for gas3/PMP22 to regulate both cell death and cell spreading: implication for the Charcot-Marie-Tooth type IA and Dejerine-Sottas diseases. Mol Biol Cell 2000, 11:2901-2914.
97. Robaglia-Schlupp A, Pizant J, Norreel JC, Passage E, Saberan-Djoneidi D, Ansaldi JL, Vinay L, Figarella-Branger D, Levy N, Clarac F, Cau P, Pellissier JF, Fontes M PMP22 overexpression causes dysmyeli-nation in mice. Brain 2002, 125:2213-2221. pt 10.
98. Turksen K, Troy TC Permeability barrier dysfunction in transgenic mice overexpressing claudin 6. Development 2002, 129:1775-1784.
99. Ma TY, Hoa NT, Tran DD, Bui V, Pedram A, Mills S, Merryfield M Cytochalasin B modulation of Caco-2 tight junction barrier: role of myosin light chain kinase. Am J Physiol Gastrointest Liver Physiol 2000, 279:G875-G885.
100. Ma TY, Hollander D, Tran LT, Nguyen D, Hoa N, Bhalla D Cytoskeletal regulation of Caco-2 intestinal monolayer paracellular permeability. J Cell Physiol 1995, 164:533-545.
101. Ma TY, Hollander D, Riga R, Bhalla D Autoradiographic determination of permeation pathway of permeability probes across intestinal and tracheal epithelia. J Lab Clin Med 1993, 122:590-600.
102. Madara JL, Barenberg D, Carlson S Effects of cytochalasin D on occluding junctions of intestinal absorptive cells: further evidence that the cytoskeleton may influence paracellular permeabilit junctional charge selectivity. J Cell Biol 1986, 102:2125-2136.
103. Madara JL Increases in guinea pig small intestinal transepithelial resistance induced by osmotic loads are accompanied by rapid alter-ations in absorptive-cell tight-junction structure. J Cell Biol 1983, 97:125-136.
104. Rassat J, Robenek H, Themann H Cytochalasin B affects the gap and tight junctions of mouse hepatocytes in vivo. Submicrosc Cytol 1982, 14:427-439.
105. Meza I, Sabanero M, Stefani E, Cereijido M Occluding junctions in MDCK cells: modulation of transepithelial permeability by the cytoskeleton. J Cell Biochem 1982, 18:407-421.
106. Bentzel CJ, Hainau B, Ho S, Hui SW, Edelman A, Anagnostopoulos T, Benedetti EL Cytoplasmic regulation of tight-junction permeability: effect of plant cytokinins. Am J Physiol 1980, 239:C75-C89.
107. Brown SS, Spudich JA Cytochalasin inhibits the rate of elongation actin filament fragments. J Cell Biol 1979, 83:657-662.
108. Brown SS, Spudich JA Mechanism of action of cytochalasin: evidence that it binds to actin filament ends. J Cell Biol 1981, 88:487-491.
109. Flanagan MD, Lin S Cytochalasins block actin filament elongation by binding to high affinity sites associated with F-actin. J Biol Chem 1980, 255:835-838.
110. Schliwa M Action of cytochalasin D on cytoskeleton networks. J Cell Biol 1992, 92:79-91.
111. Colemen TR, Mooseker MS Effects of actin filament cross-linking and filament length of actin-mysoin interaction. J Cell Biol 1985, 101:1850-1857.
112. Krugliak P, Hollander D, Schlaepfer CC, Katz KD, Dadufalza VD Ma TY Polyethylene glycol 400 penetration of the colonic epithelial barrier of the rat. Gastroenterology 1990, 99:1001-1007.
113. Krugliak P, Hollander D, Le K, Ma T, Dadufalza VD, Katz KD Regulation of polyethylene glycol 400 intestinal permeability by endogenous exogenous prostanoids Influence of non-steroidal anti-inflammatory drugs. Gut 1990, 31:417-421.
114. Hollander D, Koyama S, Dadufalza V, Tran DQ, Krugliak P, Ma T Ling KY Polyethylene glycol 900 permeability of rat intestinal and colonic segments in vivo and brush border membrane vesicles in vitro. J Lab Clin Med 1989, 113:505-515.
115. Krugliak P, Hollander D, Ma TY, Tran D, Dadufalza VD, Katz KD, Le K Mechanisms of polyethylene glycol 400 permeability of perfused rat intestine. Gastroenterology 1989, 97:1164-1170.
116. Krugliak P, Hollander D, Schlaepfer CC, Nguyen H, Ma TY Mechanisms and sites of mannitol permeability of small and large intestine in the rat. Dig Dis Sci 1994, 39:796-801.
117. Ma TY, Hollander D, Erickson RA, Truong H, Nguyen H, Krugliak P Mechanism of colonie permeation of inulin: is rat colon more permeable than small intestine?. Gastroenterology 1995, 108:12-20.
118. Loeschke K, Bentzel CJ Osmotic water flow pathways across Necturus gallbladder: role of the tight junction. Am J Physiol 1994, 266(4):G722-G730. pt 1.
119. Mullen TL, Muller M, Van Bruggen JT Role of solute drag in intestinal transport. J Gen Physiol 1985, 85:347-363.
120. Riley SA, Kim M, Sutcliffe F, Kapas M, Rowland M, Turnberg LA Effects of a non-absorbable osmotic load on drug absorption in healthy volunteers. Br J Clin Pharmacol 1992, 34:40-46.
121. Madara JL, Pappenheimer JR Structural basis for physiological regu-lation of paracellular pathways in intestinal epithelia. J Membr Biol 1987, 100:149-164.
122. Pappenheimer JR Physiological regulation of transepithelial impedance in the intestinal mucosa of rats and hamsters. J Membr Biol 1987, 100:137-148.
123. Pappenheimer JR Physiological regulation of epithelial junctions in intestinal epithelia. Acta Physiol Scand Suppl 1988, 571:43-51.
124. Pappenheimer JR Paracellular intestinal absorption of glucose crea-tinineand mannitol in normal animals: relation to body size. Am J Physiol 1990, 259(2):G290-G299. pt l.
125. Pappenheimer JR Role of pre-epithelial "unstirred" layers in absorption of nutrients from the human jejunum. J Membr Biol 2001, 179:185-204.
126. Atisook K, Carlson S, Madara JL Effects of phlorizin and sodium on glucose-elicited alterations of cell junctions in intestinal epithelia. Am J Physiol 1990, 258(1):C77-C85.
127. Atisook K, Madara JL An oligopeptide permeates intestinal tight junctions at glucose-elicited dilatations. Implications for oligopeptide absorption. Gastroenterology 1991, 100:719-724.
128. Madara JL, Carlson S, Anderson JM ZO-1 maintains its spatial distri-bution but dissociates from junctional fibrils during tight junction regulation. Am J Physiol 1993, 264(5):C1096-C1101. pt 1.
129. Madara JL Sodium-glucose co-transport and epithelial permeability. Gastroenterology 1994, 107:319-320.
130. +-coupled nutrient transport. Gastroenterology 1995, 109:1391-1396.
131. +-dependent glucose cotransporter (SGLT1): maintenance of surface expression an transport function with selective perturbation of transport kinetics and polarized expression. J Biol Chem 1996, 271:7738-7744.
132. Turner JR, Rill BK, Carlson SL, Carnes D, Kerner R, Mrsny RJ, Madara JL Physiological regulation of epithelial tight junctions is associated with myosin light-chain phosphorylation. Am J Physiol 1997, 273(4):C1378-C1385. pt 1.
133. +-glucose cotransport. Dig Dis Sci 2000, 45:2122-2126.
134. +-glucose cotransport in intestinal epithelia. Am J Physiol Cell Physiol 2001, 281:C1533-C1541.
135. Turner JR Show me the pathway! Regulation of paracellular perme-ability by Na (+) -glucose cotransport. Adv Drug Deliv Rev 2000, 41:265-281.
136. Zhao H, Shiue H, Palkon S, Wang Y, Cullinan P, Burkhardt JK, Musch MW, Chang EB, Turner JR Ezrin regulates NHE3 transloca-tion and activation after Na+-glucose cotransport. Proc Natl Acad Sci U S A 2004, 101:9485-9490.
137. +-nutrient cotransport in isolated mammalian villus enterocytes. Am J Physiol 1991, 260(1):G26-G33. pt 1.
138. + exchange is required for regulatory volume decrease after modest "physiological" volume increases in jejunal villus epithelia. J Biol Chem 1996, 271:23138-23145.
139. + and Cl-transport pathways are activated for regulatory volume decrease in jejunal villus cells. Am J Physiol 1991, 260(3):G405-G415. pt l.
140. MacLeod RJ, Hamilton JR Regulatory volume increase in mammalian jejunal villus cells is due to bumetanide-sensitive NaKC12 cotransport. Am J Physiol 1990, 258(5):G665-G674. pt 1.
141. Shiue H, Musch MW, Wang Y, Chang EB, Turner JR Akt2 phospho-rylates ezrin to trigger NHE3 translocation and activation. J Biol Chem 2005, 280:1688-1695.
142. Clayburgh DR, Rosen S, Witkowski ED, Wang F, Blair S, Dudek S, Garcia JG, Alverdy JC, Turner JR A differentiation-dependent splice variant of myosin light chain kinase MLCK1regulates epithelial tight junction permeability. J Biol Chem 2004, 279:55506-55513.
143. Lane JS, Whang EE, Rigberg DA, Hines OJ, Kwan D, Zinner MJ, McFadden DW, Diamond J Ashley SW Paracellular glucose transport plays a minor role in the unanesthetized dog. Am J Physiol 1999, 276(3):G789-G794. 5pt 1.
144. Schwartz RM, Furne JK, Levitt MD Paracellular intestinal transport of six-carbon sugars is negligible in the rat. Gastroenterology 1995, 109:1206-1213.
145. Ma TY, Boivin MA, Ye D, Pedram A, Said HM Mechanism of TNF-alpha modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression. Am J Physiol Gastrointest Liver Physiol 1905, 288:G422-G430.
146. Soderholm JD, Streutker C, Yang PC, Paterson C, Singh PK, McKay DM, Sherman PM, Croitoru K, Perdue MH Increased epithe-lial uptake of protein antigens in the ileum of Crohn's disease medi-ated by tumour necrosis factor alpha. Gut 2004, 53:1817-1824.
147. Gibson PR Increased gut permeability in Crohn's disease: is TNF the link?. Gut 2004, 53:1724-1725.
148. Ma TY, Iwamoto GK, Hoa NT, Akotia V, Pedram A, Boivin MA, Said HM TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J Physiol Gastrointest Liver Physiol 2004, 286:G367-G376.
149. Poritz LS, Garver KI, Tilberg AF, Koltun WA Tumor necrosis factor alpha disrupts tight junction assembly. J Surg Res 2004, 116:14-18.
150. Bruewer M, Luegering A, Kucharzik T, Parkos CA, Madara JL, Hopkins AM, Nusrat A Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 2003, 171:6164-6172.
151. Ferrier L, Mazelin L, Cenac N, Desreumaux P, Janin A, Emilie D, Colombel JF, Garcia-Villar R, Fioramonti J, Bueno L Stress-induced disruption of colonic epithelial barrier: role of interferon-gamma and myosin light chain kinase in mice. Gastroenterology 2003, 125:795-804.
152. Wild GE, Waschke KA, Bitton A, Thomson AB The mechanisms of prednisone inhibition of inflammation in Crohn's disease involve changes in intestinal permeabilitymucosal TNFalpha production and nuclear f kappa B expression. Aliment Pharmacol Ther 2003, 18:309-317.
153. Tazuke Y, Drongowski RA, Teitelbaum DH, Coran AG Interleukin-6 changes tight junction permeability and intracellular phospholipid content in a human enterocyte cell culture model. Pediatr Surg Int 2003, 19:321-325.
154. Han X, Fink MP, Delude RL Proinflammatory cytokines cause NO*-dependent and-independent changes in expression and localiza-tion of tight junction proteins in intestinal epithelial cell. Shock 2003, 19:229-237.
155. Kucharzik T, Williams IR Neutrophil migration across the intestinal epithelial barrier - summary of in vitro data and description of a new transgenic mouse model with doxycycline-in interleukin-8 expression in intestinal epithelial cells. Pathobiology 2002, 70:143-149./2003.
156. Yoo J, Nichols A, Song JC, Mammen J, Calvo I, Worrell RT, Cuppoletti J, Matlin K, Matthews JB Bryostatin-1 attenuates TNF-induced epithelial barrier dysfunction: role of novel PKC isozymes. Am J Physiol Gastrointest Liver Physiol 2003, 284:G703-G712.
157. Tadros T, Traber DL, Heggers JP, Herndon DN Effects of interleukin-1 alpha administration on intestinal ischemia and reperfusion injury, mucosal permeability, and bacterial translocation in burn and sep. Ann Surg 2003, 231:101-109.
158. Di Leo V, Yang PC, Berin MC, Perdue MH Factors regulating the effect of IL-4 on intestinal epithelial barrier function. Int Arch Allergy Immunol 2002, 129:219-227.
159. Mazzon E, Puzzolo D, Caputi AP, Cuzzocrea S Role of IL-10 in hepatocyte tight junction alteration in mouse model of experimental colitis. Mol Med 2002, 8:353-366.
160. Howe K, Gauldie J, McKay DM TGF-beta effects on epithelial ion transport and barrier: reduced Cl-secretion blocked by a p38 MAPK inhibitor. Am J Physiol Cell Physiol 2002, 283:C1667-C1674.
161. Madden KB, Whitman L, Sullivan C, Gause WC, Urban JF, Katona IM, Finkelman FD, Shea-Donohue T Role of STAT6 and mast cells in IL-4-and IL-13-induced alterations in murine intestinal epithelial cell function. J Immunol 2002, 169:4417-4422.
162. Nemeth ZH, Deitch EA, Szabo C, Hasko G Hyperosmotic stress induces nuclear factor-kappaB activation and interleukin-8 production in human intestinal epithelial cells. Am J Pathol 2002, 161:987-996.
163. Suenaert P, Bulteel Y, Lemmens L, Noman M, Geypens B, Van Assche G, Geboes K, Ceuppens JL, Rutgeerts P Anti-tumor necrosis factor treat-ment restores the gut barrier in Crohn's disease. Am J Gastroenterol 2002, 97:2000-2004.
164. Hollander D Crohn's disease, TNF-alpha, and the leaky gut. The chicken or the egg?. Am J Gastroenterol 2002, 97:1867-1868.
165. Nyakundi JN, Crawley B, Pentreath VW The relationships between endotoxins, nitric oxide and inflammatory cytokines in blood and intestinal tissues in experimental Trypanosoma brucei brucei infect. Parasitology 2002, 124:597-604. (pt 6).
166. Xu DZ, Lu Q, Deitch EA Nitric oxide directly impairs intestinal barrier function. Shock 2002, 17:139-145.
167. Wang Q, Hasseigren PO Heat shock response reduces intestinal permeability in septic mice: potential role of interleukin-10. Am J Physiol Regul Integr Comp Physiol 2002, 282:R669-R676.
168. Wang Q, Fang CH, Hasselgren PO Intestinal permeability is reduced and IL-10 levels are increased in septic IL-6 knockout mice. Am J Physiol Regul Integr Comp Physiol 2001, 281:R1013-R1023.
169. Shea-Donohue T, Sullivan C, Finkelman FD, Madden KB, Morris SC, Goldhill J, Pineiro-Carrero V, Urban JF The role of IL-4 in Heligmosomoides polygyrus-induced alterations in murine intestinal epithelial cell function. J Immunol 2001, 167:2234-2239.
170. Matysiak-Budnik T, Thomas-Collignon A, Megraud F, Heyman M Alterations of epithelial permeability by Helicobacter and IL-1 beta in vitro: protective effect of rebamipide. Dig Dis Sci 2001, 46:1558-1566.
171. Goto M, Deriy LY, Chen YJ, Beno DW, Uhing MR, Jiyamapa-Serna VA, Kimura RE TNF-alpha increases sensitivity to LPS in chronically catheterized rats. Am J Physiol Heart Circ Physiol 2001, 280:H2857-H2862.
172. Harren M, Barmeyer C, Schmitz H, Fromm M, Horak I, Dignass A, John M, Wiedenmann B, Schulzke JD Enhanced expression of iNOS in inflamed colons of IL-2-deficient mice does not impair colonie epithelial barrier function. Ann NY Acad Sci 2000, 915:204-213.
173. Gitter AH, Bendfeldt K, Schmitz H, Schulzke JD, Bentzel CJ, Fromm M Epithelial barrier defects in HT-29/B6 colonie cell mono-layers induced by tumor necrosis factor-alpha. Ann NY Acad Sci 2000, 915:193-203.
174. Oshima T, Laroux FS, Coe LL, Morise Z, Kawachi S, Bauer P, Grisham MB, Specian RD, Carter P, Jennings S, Granger DN, Joh T, Alexander JS Interferon-gamma and interleukin-10 reciprocally regulate endothelial junction integrity and barrier function. Microvasc Res 2001, 61:130-143.
175. Oshima T, Laroux FS, Coe LL, Morise Z, Kawachi S, Bauer P, Grisham MB, Specian RD, Carter P, Jennings S, Granger DN, Joh T, Alexander JS Interferon-gamma and interleukin-10 reciprocally regulate endothelial junction integrity and barrier function. Microvasc Res 2001, 61:291. Erratum in.
176. Roche JK, Martins CA, Cosme R, Fayer R, Guerrant RL Transforming growth factor betal ameliorates intestinal epithelial barrier disruption by Cryptosporidium parvum in vitro in the absence of mucosal T lymphocyt. Infect Immun 2000, 68:5635-5644.
177. Ceponis PJ, Botelho F, Richards CD, McKay DM Interleukins 4 and 13 increase intestinal epithelial permeability by a phosphatidylinositol 3-kinase pathway. Lack of evidence for STAT 6 involvement. J Biol Chem 2000, 275:29132-29137.
178. Madsen KL, Malfair D, Gray D, Doyle JS, Jewell LD, Fedorak RN Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. Inflamm Bowel Dis 1999, 5:262-270.
179. Fish SM, Proujansky R, Reenstra WW S ynergistic effects of interferon gamma and tumour necrosis factor alpha on T84 cell function. Gut 1999, 45:191-198.
180. Youakim A, Ahdieh M Interferon-gamma decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin. Am J Physiol 1999, 276:G1279-G1288. (5 pt 1).
181. McKay DM, Baird AW Cytokine regulation of epithelial permeability and ion transport. Gut 1999, 44:283-289.
182. Lu J, Philpott DJ, Saunders PR, Perdue MH, Yang PC, McKay DM Epithelial ion transport and barrier abnormalities evoked by superantigen-activated immune cells are inhibited by interleukin-10 but not interleukin-4. J Pharmacol Exp Ther 1998, 287:128-136.
183. Wang W, Smail N, Wang P, Chaudry IH Increased gut permeability after hemorrhage is associated with upregulation of local and systemic IL-6. J Surg Res 1998, 79:39-46.
184. Friedman GB, Taylor CT, Parkos CA, Colgan SP Epithelial perme-ability induced by neutrophil transmigration is potentiated by hypoxia: role of intracellular cAMP. J Cell Physiol 1998, 176:76-84.
185. Marano CW, Lewis SA, Garulacan LA, Soler AP, Mullin JM Tumor necrosis factor-alpha increases sodium and chloride conductance across the tight junction of CACO-2 BBE, a human intestinal epithelial cell line. J Membr Biol 1998, 161:263-274.
186. Mascarenhas JO, Goodrich ME, Eichelberger H, McGee DW Polarized secretion of IL-6 by IEC-6 intestinal epithelial cells: differential effects of IL-1 beta and TNF-alpha. Immunol Invest 1996, 25:333-340.
187. Rodriguez P, Heyman M, Candalh C, Blaton MA, Bouchaud C Tumour necrosis factor-alpha induces morphological and functional alterations of intestinal HT29 cl.l9A cell monolayers. Cytokine 1995, 7:441-448.
188. Planchon SM, Martins CA, Guerrant RL, Roche JK Regulation of intestinal epithelial barrier function by TGF-beta 1. Evidence for its role in abrogating the effect of a T cell cytokine. J Immunol 1994, 153:5730-5739.
189. McRoberts JA, Riley NE Modulation of growth factor and cytokine-induced increases in T84 cell monolayer permeability by media components. Am J Physiol 1994, 267:C537-C543. (2 pt 1).
190. Hiribarren A, Heyman M, L'Helgouac'h A, Desjeux JE Effect of cytokines on the epithelial function of the human colon carcinoma cell line HT29 cl 19A. Gut 1993, 34:616-620.
191. Adams RB, Planchon SM, Roche JK IFN-gamma modulation of epithelial barrier function. Time course, reversibility, and site of cytokine binding. J Immunol 1993, 150:2356-2363.
192. Colgan SP, Parkos CA, Delp C, Arnaout MA, Madara JL Neutrophil migration across cultured intestinal epithelial monolayers is modulated by epithelial exposure to IFN-gamma in a highly polarized fashion. J Cell Biol 1993, 120:785-798.
193. Radema SA, van Deventer SJ, Cerami A Interleukin 1 beta is expressed predominantly by enterocytes in experimental colitis. Gastroenterology 1991, 100:1180-1186. (5 pt 1).
194. Madara JL, Stafford J Interferon-gamma directly affects barrier func-tion of cultured intestinal epithelial monolayers. J Clin Invest 1989, 83:724-727.
195. Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Braakman T, DeWoody KL, Schaible TF, Rutgeerts PJ A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 1997, 337:1029-1035.
196. Sands BE Therapy of inflammatory bowel disease. Gastroenterology 2000, 118(2suppll):S68-S82.
197. Neurath MF, Fuss I, Pasparakis M, Alexopoulou L, Haralambous S, Meyerzum Buschenfelde KH, Strober W, Kollias G Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur J Immunol 1997, 27:1743-1750.
198. Powrie F, Leach MW, Mauze S, Menon S, Caddie LB, Coffman RL Inhibition of Thl responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1994, 1:553-562.
199. Watkins PE, Warren BF, Stephens S, Ward P, Foulkes R Treatment of ulcerative colitis in the cottontop tamariin using antibody to tumor necrosis factor alpha. Gut 1997, 40:628-633.
200. Peralta-Soler AP, Mullin JM, Knudsen KA, Marano CW Tissue remodeling during tumor necrosis factor-induced apoptosis in LLC-PK1 renal epithelial cells. Am J Physiol Renal Fluid Electrolyte Physiol 1996, 270:F869-F879.
201. Madara JL Maintenance of the macromolecular barrier at cell extrusion sites in intestinal epithelium: physiological rearrangement of tight junctions. J Membr Biol 1990, 16:177-184.
202. Florian P, Schoneberg T, Schulzke JD, Fromm M, Gitter AH Single-cell epithelial defects close rapidly by an actinomyosin purse string mecha-nism with functional tight junctions. J Physiol 1902, 545:485-499. (pt 2).
203. Bernent WM, Forscher P, Mooseker MS A novel cytoskeletal structure involved in purse string wound closure and cell polarity maintenance. J Cell Biol 1993, 121:565-578.
204. Ye D, Ma IH, Ma TY. Molecular mechanism of tumor necrosis factor- α regulation of intestinal epithelial tight junction barrier. Am J Physiol (In Press).
205. Spitz J, Yuhan R, Koutsouris A, Blatt C, Alverdy J, Hecht G Enteropathogenic Escherichia coli adherence to intestinal epithelial monolayers diminishes barrier function. Am J Physiol 1995, 268:G374-G379.
206. Miza-Moons MM, Schneeberger EE, Hecht GA Enteropathogenic Escherichia coli infection leads to appearance of aberrant tight junctions strands in the lateral membrane of intestinal epithelial cells. Cell Microbiol 2004, 8:783-793.
207. Savkovic SD, Koutsouris A, Hecht G Attachment of a noninvasive enteric pathogen, enteropathogenic Escherichia coli, to cultured human intestinal epithelial monolayers induces transmigration of. Infect Immun 1996, 4480-4487.
208. Yuhan R, Koutsouris A, Savkovic SD, Hecht G Enteropathogenic Escherichia coli-induced myosin light chain phosphorylation alters intestinal epithelial permeabiltiy. Gastroenterology 1997, 113:1873-1882.
209. Simonovic I, Arpin M, Koutsouris A, Falk-Krzesinski HJ, Hecht G Enteropathogenic escherichia coli activates ezrin, which participates in disruption of tight junction barrier function. Infect Immun 2001, 5679-5688.
210. Dickman KG, Hempson SJ, Anderson J, Lippe S, Zhao L, BurakoffR, Shaw RD Rotavirus alters paracellular permeability and energy metabolism in Caco-2 cells. Am J Physiol Gastrointest Liver Physiol 2000, 279:G757-G766.
211. Obert G, Peiffer I, Servin AL Rotavirus-induced structural and func-tional alterations in tight junctions of polarized intestinal Caco-2 cell monolayers. J Virol 2000, 74:4645-4651.
212. Jalonen T, Isolauri E, Heyman M, Crain-Denoyelle AM, Sillanaukee P, Koivula T Increased beta-lactoglobulin absorption during rotavirus enteritis in infants: relationship to sugar permeability. Pediatr Res 1991, 30:290-293.
213. Nava P, Lopez S, Arias CF, Islas S, Gonzalez-Mariscal L The rotavirus surface protein VP8 modulates the gate and fence function of tight junctions in epithelial cells. J Cell Sci 2004, 117:5509-5519. (pt 23).
214. Zhang Y, Lee B, Thompson M, Glass R, Cama RI, Figueroa D, Gilman R, Taylor D, Stephenson C Lactulose-mannitol intestinal permeability test in children with diarrhea caused by rotavirus and cryptosporidium. J Pediatr Gastroenterol Nutr 2000, 31:578.
215. Sears CL Molecular physiology and pathophysiology of tight junctions v. assault of the tight junction by enteric pathogens. Am J Physiol Gastrointest Liver Physiol 2000, 279:G1129-G1134.
216. Chambers FG, Koshy SS, Saidi RF, Clark DP, Moore RD, Sears CL Bacteroides fragilis toxin exhibits polar activity on monolayers of human intestinal epithelial cells (T84 cells) in vitro. Infect Immun 1997, 65:3561-3570.
217. Fasano A, Uzzau S Modulation of intestinal tight junctions by zonula occludens toxin permits enterai administration of insulin and other macromolecules in an animal model. J Clin Invest 1997, 99:1158-1164.
218. Gerhard R, Schmidt G, Hofmann F, Aktories K Activation of Rho GTPases by Escherichia coli cytotoxic necrotizing factor 1 increases intestinal permeability in Caco-2 cells. Infect Immun 1998, 66:5125-5131.
219. Nursat A, Giry M, Turner JR, Colgan SP, Parkos CA, Arnes D, Lemichez E, Boquet P, Madara JL Roh protein regulates tight junctions and peri-junctional actin organization in polarized epithelia. Proc Natl Acad Sci USA 1995, 92:10629-10633.
220. Savkovic SD, Koutsouris A, Hecht G Activation of NF-kB in intestinal epithelial cells by enteropathogenic. Escherichia coli. Am J Physiol Cell Physiol 1997, 273:C1160-C1167.
221. Simonovic I, Rosenberg J, Koutsouris A, Hecht G Enteropathogenic Escherichia coli dephosphorylates and dissociates occludin from intestinal epithelial tight junctions. Cell Microbiol 2000, 4:305-315.
222. Sonoda N, Furuse M, Sasaki H, Yonemura S, Katahira J, Horiguchi Y, Tsukita S Colstridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: evidence for direct involvement of claudins in tight junct. J Cell Biol 1999, 147:195-204.
223. Wu A, Nybom P, Magnusson KE Distinct effects of Vibrio cholerae haemagglutinin/protease on the structure and localisation of the tight junction-associated proteins occludin and ZO-1. Cell Microbiol 2000, 2:11-17.
224. Stubbe H, Berdoz J, Kraehenbuhl JP, Corthesy B Polymeric IgA is superior to monomeric IgA and IgG carrying the same variable domain in preventing Clostridium difficile toxin A damaging of T84 monolayers. J Immunol 2000, 164:1952-1960.
225. Singh U, Mitic L, Wieckowski EU, Anderson JM, McClane BA Comparative biochemical and immunocytochemical studies reveal differences in the effects of Clostridium perfringens enterotoxin on polarized Caco-2 cells vers. J Biol Chem 2001, 276:33402-33412.
226. McClane BA The complex interactions between clostridium perfringens enterotoxin and epithelial tight junctions. Toxicon 2001, 39:1781-1791.
227. Smedley JG, Fisher DJ, Sayeed S, Chakrabarti G, McClane BA The enteric toxins of Clostridium perfringens. Rev Physiol Biochem Pharmacol 2004, 152:183-204.
228. Fasano A Regulation of intercellular tight junctions by zonula occlu-dens toxin and its eukaryotic analogue zonulin. Ann N Y Acad Sci 2000, 915:214-222.
229. Chen ML, Pothoulakis C, LaMont JT Protein kinase C signaling regulates ZO-1 translocation and increased paracellular flux of T84 colonocytes exposed to Clostridium difficile toxin A. J Biol Chem 2002, 277:4247-4254.
230. Fasano A Regulation of intercellular tight junctions by zonula occlu-dens toxin and its eukaryotic analogue zonulin. Ann N Y Acad Sci 2000, 915:214-222.
231. McClane BA The complex interactions between Clostridium perfrin-gens enterotoxin and epithelial tight junctions. Toxicon 2001, 39:1781-1791.
232. Michl P, Buchholz M, Rolke M, Kunsch S, Lohr M, McClane B, Tsukita S, Leder G, Adler G, Gress TM Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology 2001, 121:678-684.
233. Dickman KG, Hempson SJ, Anderson J, Lippe S, Zhao L, BurakoffR, Shaw RD Rotavirus alters paracellular permeability and energy metabolism in Caco-2 cells. Am J Physiol Gastrointest Liver Physiol 2000, 279:G757-G766.
234. Chen ML, Pothoulakis C, LaMont JT Protein kinase C signaling regulates ZO-1 translocation and increased paracellular flux of T84 colonocytes exposed to Clostridium difficile toxin A. J Biol Chem 2002, 277:4247-4254.
235. Nusrat A, von Eichel-Streiber C, Turner JR, Verkade P, Madara JL, Parkos CA Clostridium difficile toxins disrupt epithelial barrier function by altering membrane microdomain localization of tight junction proteins. Infect Immun 2001, 69:1329-1336.
236. Hecht G, Koutsouris A, Pothoulakis C, LaMont JT, Madara JL Clostridium difficile toxin B disrupts the barrier function of T84 monolayers. Gastroenterology 1992, 102:416-423.
237. Hecht G, Pothoulakis C, LaMont JT, Madara JL Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers. J Clin Invest 1988, 82:1516-1524.
238. DeMeo MT, Mutlu EA, Keshavarzian A, Tobin MC Intestinal perme-ation and gastrointestinal disease. J Clin Gastroenterol 2002, 34:385-396.
239. Soderholm JD, Olaison G, Peterson KH, Franzen LE, Lindmark T, Wiren M, Tagesson C, Sjodahl R Augmented increase in tight junction permeability by luminal stimuli in the non-inflamed ileum of Crohn's disease. Gut 1902, 50:307-313.
240. Hollander D Intestinal permeability, leaky gut, and intestinal disorders. Curr Gastroenterol Rep 1999, 1:410-416.
241. Tibbie JA, Sigthorsson G, Bridger S, Fagerhol MK, Bjarnason I Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 2000, 119:15-22.
242. D'Inca R, Di Leo V, Corrao G, Martines D, D'Odorico A, Mestriner C, Venturi C, Longo G, Sturniolo GC Intestinal permeability test as a predictor of clinical course in Crohn's disease. Am J Gastroenterol 1999, 94:2956-2960.
243. Soderholm JD, Peterson KH, Olaison G, Franzen LE, Westrom B, Magnusson KE, Sjodahl R Epithelial permeability to proteins in the noninflamed ileum of Crohn's disease?. Gastroenterology 1999, 117:65-72.
244. Howden CW, Robertson C, Duncan A, Morris AJ, Russell RI Comparison of different measurements of intestinal permeability in inflammatory bowel disease. Am J Gastroenterol 1991, 86:1445-1449.
245. Peled Y, Watz C, Gilat T Measurement of intestinal permeability using 51Cr-EDTA. Am J Gastroenterol 1985, 80:770-773.
246. Bjarnason I, O'Morain C, Levi AJ, Peters TJ Absorption of 51 chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease. Gastroenterology 1983, 85:318-322.
247. Ukabam SO, Clamp JR, Cooper BT Abnormal small intestinal permeability to sugars in patients with Crohn's disease of the terminal ileum and colon. Digestion 1983, 27:70-74.
248. Farhadi A, Banan A, Fields J, Keshavarzian A Intestinal barrier: an interface between health and disease. J Gastroenterol Hepatol 2003, 18:479-497.
249. Kohout P Small bowel permeability in diagnosis of celiac disease and monitoring of compliance of a gluten-free diet (gut permeability in celiac disease). Acta Medica (Hradec Kralove) 2001, 44:101-104.
250. Johnston SD, Smye M, Watson RP Intestinal permeability tests in coeliac disease. Clin Lab 2001, 47(3-4):143-150.
251. Cummins AG, Thompson FM, Butler RN, Cassidy JC, Gillis D, Lorenzetti M, Southcott EK, Wilson PC Improvement in intestinal permeability precedes morphometric recovery of the small intestine in coeliac disease. Clin Sci (Lond) 2001, 100:379-386.
252. Johnston SD, Smye M, Watson RG, McMillan SA, Trimble ER, Love AH Lactulose-mannitol intestinal permeability test: a useful screening test for adult coeliac disease. Ann Clin Biochem 2000, 37:512-519. pt4.
253. Schulzke JD, Bentzel CJ, Schulzke I, Riecken EO, Fromm M Epithelial tight junction structure in the jejunum of children with acute and treated celiac sprue. Pediatr Res 1998, 43:435-441. (4 pt 1).
254. Smecuol E, Bai JC, Vazquez H, Kogan Z, Cabanne A, Niveloni S, Pedreira S, Boerr L, Maurino E, Meddings JB Gastrointestinal perme-ability in celiac disease. Gastroenterology 1997, 112:1129-1136.
255. Vogelsang H, Wyatt J, Penner E, Lochs H Screening for celiac disease in first-degree relatives of patients with celiac disease by lactulose/mannitol test. Am J Gastroenterol 1995, 90:1838-1842.
256. Lobley RW, Burrows PC, Warwick R, Dawson DJ, Holmes R Simultaneous assessment of intestinal permeability and lactose tolerance with orally administered raffinose, lactose and L-arabinose. Clin Sci (Lond) 1990, 79:175-183.
257. Martines D, Morris AI, Gilmore IT, Williams A, Stockdale H, Critchley M, Smith GA, Billington D Comparison between the cellobiose/mannitol and 51Cr-labelled ethylenediaminetetra-acetate absorption tests in the detection of coeliac disease. Clin Sci (Lond) 1988, 75:375-378.
258. 51Cr-EDTA/14C-mannitol intestinal permeability test. Clinical use in screening for coeliac disease. Scand J Gastroenterol 1988, 23:171-177.
259. Stenson WF, Korzenik J Inflammatory bowel disease. Textbook of gastroenterology 2003, 1699-1749. Lippincott Williams & Wilkins, Philadelphia. 4th ed. T. Yamada, D.H. Alpers, N. Kaplowitz, L. Laine, C. Owynag, D.W. Powell (Eds.).
260. Strobel S, Brydon WG, Ferguson A Cellobiose/mannitol sugar perme-ability test complements biopsy histopathology in clinical investigation of the jejunum. Gut 1984, 25:1241-1246.
261. Gryboski JD, Thayer WR, Gryboski WA, Gabrielson IW, Spiro HM A defect in disaccharide metabolism after gastrojejunostomy. N Engl J Med 1963, 268:78-80.
262. Pearson AD, Eastham EJ, Laker MF, Craft AW, Nelson R Intestinal permeability in children with Crohn's disease and coeliac disease. Br Med J (Clin Res Ed) 1982, 285:20-21.
263. Hamilton I, Cobden I, Rothwell J, Axon AT Intestinal permeability in coeliac disease: the response to gluten withdrawal and single-dose gluten challenge. Gut 1982, 23:202-210.
264. Cobden I, Rothwell J, Axon AT Intestinal permeability and screening tests for coeliac disease. Gut 1980, 21:512-518.
265. Menzies IS, Laker MF, Pounder R, Bull J, Heyer S, Wheeler PG, Creamer B Abnormal intestinal permeability to sugars in villous atrophy. Lancet 1979, 2:1107-1109.
266. Cobden I, Dickinson RJ, Rothwell J, Axon AT Intestinal permeability assessed by excretion ratios of two molecules: results in coeliac disease. Br Med J 1978, 2:1060.
267. Rao RK, Seth A, Sheth P Recent advances in alcoholic liver disease. I. Role of intestinal permeability and endotoxemia in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 2004, 286:G881-G884.
268. Parlesak A, Schafer C, Schutz T, Bode JC, Bode C Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver diseas. J Hepatol 2000, 32:742-747.
269. Tamai H, Kato S, Horie Y, Ohki E, Yokoyama H, Ishii H Effect of acute ethanol administration on the intestinal absorption of endotoxin in rats. Alcohol Clin Exp Res 2000, 24:390-394.
270. Ersoz G, Aydin A, Erdem S, Yuksel D, Akarca U, Kumanlioglu K Intestinal permeability in liver cirrhosis. Eur J Gastroenterol Hepatol 1999, 11:409-412.
271. Keshavarzian A, Holmes EW, Patel M, Iber F, Fields JZ, Pethkar S Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage. Am J Gastroenterol 1999, 94:200-207.
272. Mahmud T, Scott DL, Bjarnason I A unifying hypothesis for the mechanism of NSAID related gastrointestinal toxicity. Ann Rheum Dis 1996, 55:211-213.
273. Bjarnason I, Hayllar J, MacPherson AJ, Russell AS Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 1993, 104:1832-1847.
274. Bjarnason I, Smethurst P, Macpherson A, Walker F, McElnay JC, Passmore AP, Menzies IS Glucose and citrate reduce the permeability changes caused by indomethacin in humans. Gastroenterology 1992, 102:1546-1550.
275. Bjarnason I, Fehilly B, Smethurst P, Menzies IS, Levi AJ Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man. Gut 1991, 32:275-277.
276. Bjarnason I, Smethurst P, Clark P, Menzies I, Levi J, Peters T Effect of prostaglandin on indomethacin-induced increased intestinal perme-ability in man. Scand J Gastroenterol Suppl 1989, 164:97-103.
277. Bjarnason I, Zanelli G, Smith T, Prouse P, Williams P, Smethurst P, Delacey G, Gumpel MJ, Levi AJ Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans. Gastroenterology 1987, 93:480-489.
278. Bjarnason I, Zanelli G, Smith T, Smethurst P, Price AB, Gumpel MJ, Levi AJ The pathogenesis and consequence of non steroidal anti-inflammatory drug induced small intestinal inflammation in man. Scand J Rheumatol Suppl 1987, 64:55-62.
279. Bjarnason I, Williams P, Smethurst P, Peters TJ, Levi AJ Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut 1986, 27:1292-1297.
280. Bjarnason I, Zanelli G, Prouse P, Williams P, Gumpel MJ, Levi AJ Effect of non-steroidal anti-inflammatory drugs on the human small intestine. Drugs 1986, 32(suppl 1):35-41.
281. Bjarnason I, Williams P, So A, Zanelli GD, Levi AJ, Gumpel JM, Peters TJ, Ansell B Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs. Lancet 1984, 2:1171-1174.
282. Ma TY Intestinal epithelial barrier dysfunction in Crohn's disease. Proc Soc Exp Biol Med 1997, 214:318-327.
283. Hollander D The intestinal permeability barrier. A hypothesis as to its regulation and involvement in Crohn's disease. Scand J Gastroenterol 1992, 27:721-726.
284. Hollander D Crohn's disease - a permeability disorder of the tight junction?. Gut 1988, 29:1621-1624.
285. Bjarnason I, MacPherson A, Hollander D Intestinal permeability: an overview. Gastroenterology 1995, 108:1566-1581.
286. Marshall JK, Thabane M, Garg AX, Clark W, Meddings J, Collins SM WEL Investigators. Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontari. Aliment Pharmacol Ther 2004, 20(11-12):1317-1322.
287. Verdu EF, Collins SM Microbial-gut interactions in health and disease Irritable bowel syndrome. Best Pract Res Clin Gastroenterol 2004, 18:315-321.
288. Collins SM Stress and the gastrointestinal tract IV Modulation of intes-tinal inflammation by stress: basic mechanisms and clinical relevance. Am JPhysiol Gastrointest Liver Physiol 2001, 280:G315-G318.
289. Spiller RC, Jenkins D, Thornley JP, Hebden JM, Wright T, Skinner M, Neal KR Increased rectal mucosal enteroendocrine cells, T lympho-cytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000, 47:804-811.
290. Chadwick VS, Phillips SF, Hofmann AF Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). II. Application to normal and abnormal permeability states and animals. Gastroenterology 1977, 73:247-251.
291. May GR, Sutherland LM, Meddings JB Lactulose/mannitol perme-ability is increased in relatives of patients with Crohn's disease. Gastroenterology 1992, 102:A934.
292. Hollander D, Ricketts D, Boyd CAR The importance of "probe" molecular geometry in determining intestinal permeability. Can J Gastroenterol 1988, 2:35a-38a.
293. Clemente MG, De Virgiliis S, Kang JS, Macatagney R, Musu MP, Di Pierro MR, Drago S, Congia M, Fasano A Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut 2003, 52:218-223.
294. Fasano A Intestinal zonulin: open sesame. Gut 2001, 49:159-162.
295. Fasano A Regulation of intercellular tight junctions by zonula occlu-dens toxin and its eukaryotic analogue zonulin. Ann N Y Acad Sci 2000, 915:214-222.
296. Fasano A, Not T, Wang W, Uzzau S, Berti I, Tommasini A, Goldblum SE Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet 2000, 355:1518-1519.
297. Lu R, Wang W, Uzzau S, Vigorito R, Zielke HR, Fasano A Affinity purification and partial characterization of the zonulin/zonula occlu-dens toxin (Zot) receptor from human brain. J Neurochem 2000, 74:320-326.
298. Yacyshyn BR, Meddings JB CD45RO expression on circulating CD 19+ B cells in Crohn's disease correlates with intestinal perme-ability. Gastroenterology 1995, 108:132-137.
299. Yacyshyn BR, Pilarski LM Expression of CD45RO on circulating CD19+ B-cells in Crohn's disease. Gut 1993, 34:1698-1704.
300. Marin ML, Greenstein AJ, Geller SA, Gordon RE, Aufses AH A freeze fracture study of Crohn's disease of the terminal ileum: changes in epithelial tight junction organization. Am J Gastroenterol 1983, 78:537-547.
301. Dvorak AM, Connel AB, Dickerson GR Crohn's disease: electron microscopic studies. Ann Int Med 1979, 14:259-306.
302. Dvorak AM, Dickersin GR Crohn's disease: transmission electron microscopic studies. I. Barrier function. Possible changes related to alterations of cell coat, mucous coat, epithelial and Paneth cells. Hum Pathol 1980, 11(5 suppl):561-571.
303. Dvorak AM, Connell AB, Dickersin GR Crohn's disease: a scanning electron microscopic study. Hum Pathol 1979, 10:165-177.
304. Dvorak AM, Dickersin GR Crohn's disease: electron microscopic studies. Pathol Annu 1979, 14:259-306. (pt 2).
305. Kaufmann HJ, Taubin HL Nonsteroidal anti-inflammatory drugs acti-vate quiescent inflammatory bowel disease. Ann Intern Med 1987, 107:513-516.
306. Bjarnason I, Ward K, Peters TJ The leaky gut of alcoholism; possible route of entry for toxic compounds. Lancet 1984, 1:179-182.
307. Bjarnason I, Peters TJ Intestinal permeability, non-steroidal anti-inflammatory drug enteropathy and inflammatory bowel disease: an overview. Gut 1989, 30:22-28.
308. Blaser MJ, Miller RA, Lacher J, Singleton JW Patients with active Crohn's disease have elevated serum antibodies to antigens of seven enteric bacterial pathogens. Gastroenterology 1984, 87:888-894.
309. Wyatt J, Vogelsang H, Hubl W, Waldhoer T, Lochs H Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 1993, 341:1437-1439.
310. Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RI Gastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs. N Engl J Med 1992, 327:749-754.
311. Hollander D, Vadheim CM, Brettholz E, Petersen GM, Delahunty T, Rotter JI Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann Intern Med 1986, 105:883-885.
312. Katz KD, Hollander D, Vadheim CM, McElree C, Delahunty T, Dadufalza VD, Krugliak P, Rotter JI Intestinal permeability in patients with Crohn's disease and their healthy relatives. Gastroenterology 1989, 97:927-931.
313. Olaison G, Sjodahl R, Tagesson C Decreased gastrointestinal absorp-tion of peroral polyethyleneglycols (PEG 1000) in Crohn's disease. Acta Chir Scand 1987, 153:373-377.
314. Sanderson IR, Boulton P, Menzies I, Walker-Smith JA Improvement of abnormal lactulose/rhamnose permeability in active Crohn's disease of the small bowel by an elemental diet. Gut 1987, 28:1073-1076.
315. 51Cr-EDTA in patients with active inflammatory bowel disease. Clin Invest Med 1988, 11:151-155.
316. Andre F, Andre C, Emery Y, Forichon J, Descos L, Minaire Y Assessment of the lactulose-mannitol test in Crohn's disease. Gut 1988, 29:511-515.
317. 51Cr-labelled ethylenediaminetetraacetic acid in patients with Crohn's disease and their healthy relatives. Scand J Gastroenterol 1989, 24:993-998.
318. Resnick RH, Royal H, Marshall W, Barron R, Werth T Intestinal permeability in gastrointestinal disorders. Use of oral [99mTc]DTPA. Dig Dis Sci 1990, 35:205-211.
319. Issenman RM, Jenkins RT, Radoja C Intestinal permeability compared in pediatrie and adult patients with inflammatory bowel disease. Clin Invest Med 1993, 16:187-196.
320. Munkholm P, Langholz E, Hollander D, Thornberg K, Orholm M, Katz KD, Binder V Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives. Gut 1994, 35:68-72.
321. Zamora SA, Hilsden RJ, Meddings JB, Butzner JD, Scott RB, Sutherland LR Intestinal permeability before and after ibuprofen in families of children with Crohn's disease. Can J Gastroenterol 1999, 13:31-36.
322. Soderholm JD, Olaison G, Lindberg E, Hannestad U, Vindels A, Tysk C, Jarnerot G, Sjodahl R Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: an inherited defect in mucosal defence?. Gut 1999, 44:96-100.
323. Hilsden RJ, Meddings JB, Sutherland LR Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease. Gastroenterology 1996, 110:1395-1403.
324. Harris CE, Griffiths RD, Freestone N, Billington D, Atherton ST, Macmillan RR Intestinal permeability in the critically ill. Intensive Care Med 1992, 18:38-41.
325. Doig CJ, Sutherland LR, Sandham JD, Fick GH, Verhoef M, Meddings JB Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. Am J Respir Crit Care Med 1998, 158:444-451.
326. Wang Q, Pantzar N, Jeppsson B, Westrom BR, Karlsson BW Increased intestinal marker absorption due to regional permeability changes and decreased intestinal transit during sepsis in the rat. Scand J Gastroenterol 1994, 29:1001-1008.
327. Yu P, Martin CM Increased gut permeability and bacterial translocation in Pseudomonas pneumonia-induced sepsis. Crit Care Med 2000, 28:2573-2577.
328. Ziegler TR, Smith RJ, O'Dwyer ST, Demling RH, Wilmore DW Increased intestinal permeability associated with infection in burn patients. Arch Surg 1988, 123:1313-1319.
329. Ryan CM, Yarmush ML, Burke JF, Tompkins RG Increased gut permeability early after burns correlates with the extent of burn injury. Crit Care Med 1992, 20:1508-1512.
330. Epstein MD, Tchervenkov JI, Alexander JW, Johnson JR, Vester JW Increased gut permeability following burn trauma. Arch Surg 1991, 126:198-200.
331. LeVoyer T, CioffiWG, Pratt L, Shippee R, McManus WF, Mason AD, Pruitt BA Alterations in intestinal permeability after thermal injury. Arch Surg 1992, 127:26-30.
332. Kavanaugh MJ, Clark C, Goto M, Kovacs EJ, Gamelli RL, Sayeed MM, Choudhry MA Effect of acute alcohol ingestion prior to burn injury on intestinal bacterial growth and barrier function. Burns 2005, 31:290-296.
333. Moseley PL, Gapen C, Wallen ES, Walter ME, Peterson MW Thermal stress induces epithelial permeability. Am J Physiol 1994, 267:C425-C434. (2 pt 1).
334. Prosser C, Stelwagen K, Cummins R, Guerin P, Gill N, Milne C Reduction in heat-induced gastrointestinal hyperpermeability in rats by bovine colostrum and goat milk powders. J Appl Physiol 2004, 96:650-654.
335. Lambert GP, GisolfiCV, Berg DJ, Moseley PL, Oberley LW, Kregel KC Selected contribution: hyperthermia-induced intestinal permeability and the role of oxidative and nitrosative stress. J Appl Physiol 2002, 92:1750-1761.
336. Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 1993, 123:1777-1788. (6 pt 2).
337. Ebnet K, Suzuki A, Ohno S, Vestweber D Junctional adhesion mole-cules (JAMs): more molecules with dual functions?. J Cell Sci 2004, 117:19-29. (pt 1).
338. Betanzos A, Huerta M, Lopez-Bayghen E, Azuara E, Amerena J, Gonzalez-Mariscal L The tight junction protein ZO-2 associates with Jun, Fos and C/EBP transcription factors in epithelial cells. Exp Cell Res 2004, 292:51-66.
339. Hamazaki Y, Itoh M, Sasaki H, Furuse M, Tsukita S Multi-PDZ domain
340. Hurd TW, Gao L, Roh MH, Macara IG, Margolis B Direct interaction of two polarity complexes implicated in epithelial tight junction assembly. Nat Cell Biol 2003, 5:137-142.
341. Balda MS, Anderson JM, Matter K The SH3 domain of the tight junction protein ZO-1 binds to a serine protein kinase that phosphor-ylates a region C-terminal to this domain. FEBS Lett 1996, 399:326-332.
342. Wu X, Hepner K, Castelino-Prabhu S, Do D, Kaye MB, Yuan XJ, Wood J, Ross C, Sawyers CL, Whang YE Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2. Proc Natl Acad Sci USA 2000, 97:4233-4238.
343. Nakamura T, Blechman J, Tada S, Rozovskaia T, Itoyama T, Bullrich F, Mazo A, Croce CM, Geiger B, Canaani E ASHl protein, a putative transcription factor encoded by a human homologue of the Drosophila ashl gene, localizes to both nuclei and cell-cell tight junctions. Proc Natl Acad Sci USA 2000, 97:7284-7289.
344. Lapierre LA, Tuma PL, Navarre J, Goldenring JR, Anderson JM VAP-33 localizes to both an intracellular vesicle population and with occludin at the tight junction. J Cell Sci 1999, 112:3723-3732. pt 21.
345. Yeaman C, GrindstaffKK, Nelson WJ Mechanism of recruiting Sec6/8 (exocyst) complex to the apical junctional complex during polarization of epithelial cells. J Cell Sci 2004, 117:559-570. (pt 4).
346. Guillemot L, Hammar E, Kaister C, Ritz J, Caille D, Jond L, Bauer C, Meda P, Citi S Disruption of the cingulin gene does not prevent tight junction formation but alters gene expression. J Cell Sci 2004, 117:5245-5256. (pt 22).
347. Farquhar MG and Palade GE. Junctional complexes in various epithelia. J Cell Biol.
348. Ye D, Ma IH, Ma TY. Molecular mechanism of tumor necrosis factor- α regulation of intestinal epithelial tight junction barrier. Am J Physiol (In Press).